Zerodha's Nithin Kamath says India's response to affordable weight-loss drugs is 'weird'. Here's why
Generic GLP-1 weight-loss drugs have become significantly more affordable in India, but adoption remains slower than expected. Zerodha co-founder Nithin Kamath believes the issue isn't cost but long-term commitment, self-injections and conservative prescribing practices.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
